Concepedia

Kenjiro Ito

KI

9

Publications

476

Citations

9

H-Index

1964

Active since

Affiliations

Taiho Pharmaceutical (Japan)(Current)

University of Kansas Medical Center

Kenjiro Ito is an author at Taiho Pharmaceutical (Japan) specializing in medicine, chromatography, and clinical chemistry.

Top concepts

Publications per year

1964–2020

9

Publications

9

Futibatinib Is a Novel Irreversible FGFR 1–4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors

Hiroshi Sootome, Hidenori Fujita, Kenjiro Ito et al. · Cancer Research · 2020 · 184 citations · Full text

TAS-116, a Highly Selective Inhibitor of Heat Shock Protein 90α and β, Demonstrates Potent Antitumor Activity and Minimal Ocular Toxicity in Preclinical Models

Shuichi Ohkubo, Yasuo Kodama, Hiromi Muraoka et al. · Molecular Cancer Therapeutics · 2014 · 128 citations

Selective Eradication of Erythropoiesis by Actinomycin D as the Result of Interference with Hormonally Controlled Effector Pathway of Cell Differentiation

Kurt R. Reißmann, Kenjiro Ito · Blood · 1966 · 40 citations · Full text

Protein Metabolism and Erythropoiesis

Kenjiro Ito, John W. Schmaus, Kurt R. Reißmann · Acta Haematologica · 1964 · 35 citations

, , +6

INFLUENCE OF DISAPPEARANCE RATE AND DISTRIBUTION SPACE ON PLASMA CONCENTRATION OF ERYTHROPOIETIN IN NORMAL RATS.

D. Diederich, Kenjiro Ito, John W. Schmaus · PubMed · 1965 · 24 citations

Rows per page

1–5 of 9